Skip to main content

Main menu

  • HOME
  • ONLINE FIRST
  • CURRENT ISSUE
  • ALL ISSUES
  • AUTHORS & REVIEWERS
  • SUBSCRIBE
  • BJGP LIFE
  • MORE
    • About BJGP
    • Conference
    • Advertising
    • eLetters
    • Alerts
    • Video
    • Audio
    • Librarian information
    • Resilience
    • COVID-19 Clinical Solutions
  • RCGP
    • BJGP for RCGP members
    • BJGP Open
    • RCGP eLearning
    • InnovAIT Journal
    • Jobs and careers

User menu

  • Subscriptions
  • Alerts
  • Log in

Search

  • Advanced search
British Journal of General Practice
Intended for Healthcare Professionals
  • RCGP
    • BJGP for RCGP members
    • BJGP Open
    • RCGP eLearning
    • InnovAIT Journal
    • Jobs and careers
  • Subscriptions
  • Alerts
  • Log in
  • Follow bjgp on Twitter
  • Visit bjgp on Facebook
  • Blog
  • Listen to BJGP podcast
  • Subscribe BJGP on YouTube
Intended for Healthcare Professionals
British Journal of General Practice

Advanced Search

  • HOME
  • ONLINE FIRST
  • CURRENT ISSUE
  • ALL ISSUES
  • AUTHORS & REVIEWERS
  • SUBSCRIBE
  • BJGP LIFE
  • MORE
    • About BJGP
    • Conference
    • Advertising
    • eLetters
    • Alerts
    • Video
    • Audio
    • Librarian information
    • Resilience
    • COVID-19 Clinical Solutions
Letters

Recommendations for the recognition, diagnosis, and management of long COVID

Huw Jenkins
British Journal of General Practice 2022; 72 (719): 259. DOI: https://doi.org/10.3399/bjgp22X719537
Huw Jenkins
British Society for Allergy and Clinical Immunology (BSACI), London. Email:
Roles: Consultant Physician
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: huw.jenkins1@nhs.net
  • Article
  • Info
  • eLetters
  • PDF
Loading

All letters are subject to editing and may be shortened. General letters can be sent to bjgpdisc{at}rcgp.org.uk (please include your postal address for publication), and letters responding directly to BJGP articles can be submitted online via eLetters. We regret we cannot notify authors regarding publication.

For submission instructions visit: bjgp.org/letters

The British Society for Allergy and Clinical Immunology (BSACI) would like to respond to the article by Nurek et al.1 We appreciate this is a growing area of interest, and that further research is needed, but we feel that this article makes conclusions that are not supported by evidence, and which has the potential to trigger unnecessary referrals to allergy and immunology clinics, which are already facing huge pressures.

In Box 1, described as ‘ Known examples of conditions associated with long COVID’, included are ‘Mast cell activation, including urticaria, angioedema, and histamine intolerance’, along with ‘New-onset allergies and anaphylaxis’. It has been recognised that SARS-CoV-2 infection can be associated with urticaria and angioedema,2 as is the case with many infections,3 but there is no evidence to suggest that acute infection or long COVID causes new allergic sensitisation or manifestations of allergic or atopic diseases including anaphylaxis. Similarly, it is not clear that urticaria itself is increased in long COVID, after the initial phase of infection. The term ‘histamine intolerance’ can be misleading in that there is no clear evidence to support a role for ingested histamine in chronic urticaria, a well-recognised auto-immune disorder.4,5

The authors draw parallels between the symptoms of ‘mast cell activation syndrome (MCAS)’ and those of long COVID, and suggest that this diagnosis should be considered in patients with a broad range of symptoms. They acknowledge as do we that MCAS is a controversial area with no clear diagnostic criteria. An association between autonomic dysfunction and mast cell disorders is suggested, although in fact this remains unproven and based predominantly on symptom reporting.6 They then offer recommendations for treatment including low-histamine diets, antihistamines, and montelukast, and suggest referral to immunology or allergy specialists. No evidence is provided to support the use of low-histamine diets, or an association between MCAS and long COVID. This is an interesting area for further research, but the evidence is not there for this to be put forward as a recommendation to family doctors.

We understand that the article represents the lived experience of a number of doctors dealing with long COVID, and is an attempt to shed light on possible mechanisms and treatment approaches. However, the casual reader may assume the recommendations carry the same weight as for instance a National Institute for Health and Care Excellence (NICE) guideline.

We are concerned that no specialists in the field of allergy or immunology were involved in the publication. We do not feel that referral of patients with non-specific symptoms to allergy/immunology clinics is appropriate, unless there is a clear clinical question requiring assessment of a possible specific allergic trigger.

NICE has published detailed guidance for investigation and management of long COVID.7 Scottish Intercollegiate Guidelines Network (SIGN) guidelines also include specific advice on management of urticaria and angioedema in the context of long COVID, which emphasises that no different management strategies are required.8 Considerable investment has been made by NHS England into long COVID services, which are now starting to develop across the UK.9 We would encourage family doctors to use the published NICE and SIGN guidance when assessing patients and to use approved referral pathways.

  • © British Journal of General Practice 2022

REFERENCES

  1. 1.↵
    1. Nurek M,
    2. Rayner C,
    3. Freyer A,
    4. et al.
    (2021) Recommendations for the recognition, diagnosis, and management of long COVID: a Delphi study. Br J Gen Pract, DOI: https://doi.org/10.3399/BJGP.2021.0265.
  2. 2.↵
    1. Abuelgasim E,
    2. Dona ACM,
    3. Sondh RS,
    4. Harky A
    (2021) Management of urticaria in COVID-19 patients: a systematic review. Dermatol Ther 34, 1, e14328.
    OpenUrlCrossRef
  3. 3.↵
    1. Wedi B,
    2. Raap U,
    3. Wieczorek D,
    4. Kapp A
    (2009) Urticaria and infections. Allergy Asthma Clin Immunol 5, 1, 10.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Zuberbier T,
    2. Aberer W,
    3. Asero R,
    4. et al.
    (2018) The EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria. The 2017 revision and update. Allergy 73, 7, 1393–1414.
    OpenUrlPubMed
  5. 5.↵
    1. Powell RJ,
    2. Leech SC,
    3. Till S,
    4. et al.,
    5. British Society for Allergy and Clinical Immunology
    (2015) BSACI guideline for the management of chronic urticaria and angioedema. Clin Exp Allergy 45, 3, 547–565.
    OpenUrl
  6. 6.↵
    1. Kohn A,
    2. Chang C
    (2020) The relationship between hypermobile Ehlers–Danlos syndrome (hEDS), postural orthostatic tachycardia syndrome (POTS), and mast cell activation syndrome (MCAS). Clin Rev Allergy Immunol 58, 3, 273–297.
    OpenUrl
  7. 7.↵
    1. National Institute for Health and Care Excellence
    (2022) COVID-19 rapid guideline: managing the longterm effects of COVID-19 NG188 (NICE, London) https://www.nice.org.uk/guidance/ng188/ (accessed 10 May 2022).
  8. 8.↵
    1. Scottish Government
    (2021) Annex C. Managing the long-term effects of COVID-19, https://www.sign.ac.uk/media/1931/sg-long-covid-isn-version-20.pdf (accessed 10 May 2022).
  9. 9.↵
    1. NHS
    (2021) Long COVID: the NHS plan for 2021/2022, https://www.england.nhs.uk/coronavirus/wp-content/uploads/sites/52/2021/06/C1312-long-covid-plan-june-2021.pdf (accessed 10 May 2022).
Back to top
Previous ArticleNext Article

In this issue

British Journal of General Practice: 72 (719)
British Journal of General Practice
Vol. 72, Issue 719
June 2022
  • Table of Contents
  • Index by author
Download PDF
Article Alerts
Or,
sign in or create an account with your email address
Email Article

Thank you for recommending British Journal of General Practice.

NOTE: We only request your email address so that the person to whom you are recommending the page knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Recommendations for the recognition, diagnosis, and management of long COVID
(Your Name) has forwarded a page to you from British Journal of General Practice
(Your Name) thought you would like to see this page from British Journal of General Practice.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Recommendations for the recognition, diagnosis, and management of long COVID
Huw Jenkins
British Journal of General Practice 2022; 72 (719): 259. DOI: 10.3399/bjgp22X719537

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Recommendations for the recognition, diagnosis, and management of long COVID
Huw Jenkins
British Journal of General Practice 2022; 72 (719): 259. DOI: 10.3399/bjgp22X719537
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
  • Mendeley logo Mendeley

Jump to section

  • Top
  • Article
    • REFERENCES
  • Info
  • eLetters
  • PDF

More in this TOC Section

  • Author response
  • Development and external validation of a new clinical prediction model for early recognition of sepsis
Show more Letters

Related Articles

Cited By...

Intended for Healthcare Professionals

BJGP Life

BJGP Open

 

@BJGPjournal's Likes on Twitter

 
 

British Journal of General Practice

NAVIGATE

  • Home
  • Current Issue
  • All Issues
  • Online First
  • Authors & reviewers

RCGP

  • BJGP for RCGP members
  • BJGP Open
  • RCGP eLearning
  • InnovAiT Journal
  • Jobs and careers

MY ACCOUNT

  • RCGP members' login
  • Subscriber login
  • Activate subscription
  • Terms and conditions

NEWS AND UPDATES

  • About BJGP
  • Alerts
  • RSS feeds
  • Facebook
  • Twitter

AUTHORS & REVIEWERS

  • Submit an article
  • Writing for BJGP: research
  • Writing for BJGP: other sections
  • BJGP editorial process & policies
  • BJGP ethical guidelines
  • Peer review for BJGP

CUSTOMER SERVICES

  • Advertising
  • Contact subscription agent
  • Copyright
  • Librarian information

CONTRIBUTE

  • BJGP Life
  • eLetters
  • Feedback

CONTACT US

BJGP Journal Office
RCGP
30 Euston Square
London NW1 2FB
Tel: +44 (0)20 3188 7400
Email: journal@rcgp.org.uk

British Journal of General Practice is an editorially-independent publication of the Royal College of General Practitioners
© 2022 British Journal of General Practice

Print ISSN: 0960-1643
Online ISSN: 1478-5242